ANN ARBOR, MI--(Marketwire - October 15, 2007) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today that David A. Newsome, M.D. has joined the senior management team of Pipex as Chief Scientific Officer.
